Hospital Parc Tauli

Barcelona 8208

0 studies enrolling now · 4 studies all time

What they study most

Androgen-Independent Prostatic Cancer, Androgen-Independent Prostatic Neoplasms, Androgen-Insensitive Prostatic Cance, Androgen-Resistant Prostatic Cancer, EGFR Exon 20 Mutation, Gastric Adenocarcinoma, Hormone Refractory Prostatic Cancer, Immune Checkpoint Inhibitor, Immunotherapy, Inhibitory Checkpoint Molecule, Non Small Cell Lung Cancer, Non-small Cell Lung Cancer

Studies at this site

• A Phase 1/2 Trial of CLN-081 in Patients With Non-Small Cell Lung Cancer — Running, not enrolling
• A Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate Cancer — Completed
• Zimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Patients With Untreated Metastatic Non-Small Cell Lung Cancer — Running, not enrolling
• Andecaliximab With mFOLFOX6 as First Line Treatment for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma — Completed